Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Phase 3

Terminated

Conditions: Extragonadal Germ Cell Tumor
Testicular Germ Cell Tumor

Interventions: Drug: cisplatin
Drug: ifosfamide
Drug: paclitaxel
Drug: vinblastine

First Posted Date: 2003-11-06

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1

Registration Number: NCT00072215

Locations: 🇺🇸
Broward General Medical Center, Fort Lauderdale, Florida, United States
🇺🇸
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
Palm Beach Cancer Institute - West Palm Beach, West Palm Beach, Florida, United States

and more 76 locations

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

Phase 3

Completed

Conditions: Kidney Cancer

Interventions: Biological: bevacizumab
Biological: recombinant interferon alfa

First Posted Date: 2003-11-06

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 732

Registration Number: NCT00072046

Locations: 🇺🇸
Doctors Hospital at Ohio Health, Columbus, Ohio, United States
🇺🇸
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Rebecca and John Moores UCSD Cancer Center, San Diego, California, United States

and more 488 locations

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

Phase 2

Completed

Conditions: Leukemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasms

Interventions: Drug: vatalanib

First Posted Date: 2003-11-06

Last Posted Date: 2016-08-01

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 155

Registration Number: NCT00072475

Locations: 🇺🇸
Elkhart General Hospital, Elkhart, Indiana, United States
🇺🇸
Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale, Florida, United States
🇺🇸
Galesburg Clinic, PC, Galesburg, Illinois, United States

and more 65 locations

Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: cisplatin
Drug: etoposide
Drug: irinotecan hydrochloride
Radiation: radiation therapy

First Posted Date: 2003-11-05

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 78

Registration Number: NCT00072527

Locations: 🇺🇸
McDonough District Hospital, Macomb, Illinois, United States
🇺🇸
Hudner Oncology Center at Saint Anne's Hospital, Fall River, Massachusetts, United States
🇺🇸
Saint Luke's Hospital, Chesterfield, Missouri, United States

and more 73 locations

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: filgrastim
Drug: cyclophosphamide
Drug: doxorubicin hydrochloride
Drug: etoposide
Drug: prednisone
Drug: vincristine sulfate

First Posted Date: 2003-11-05

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 59

Registration Number: NCT00005964

Locations: 🇺🇸
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
🇺🇸
Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸
State University of New York - Upstate Medical University, Syracuse, New York, United States

and more 44 locations

Genetic Study of Patients and Families With a History of Colorectal Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: DNA stability analysis
Genetic: gene rearrangement analysis

First Posted Date: 2003-10-29

Last Posted Date: 2016-07-04

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 1500

Registration Number: NCT00003648

Locations: 🇺🇸
CCOP - Cedar Rapids Oncology Project, Cedar Rapids, Iowa, United States
🇺🇸
CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States

and more 9 locations

Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss

Phase 1

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Leukemia
Lymphoma

Interventions: Dietary Supplement: omega-3 fatty acid

First Posted Date: 2003-10-22

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 63

Registration Number: NCT00003077

Locations: 🇺🇸
CCOP - Christiana Care Health Services, Wilmington, Delaware, United States
🇺🇸
Holden Comprehensive Cancer Center at The University of Iowa, Iowa City, Iowa, United States
🇺🇸
North Shore University Hospital, Manhasset, New York, United States

and more 2 locations

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer
Drug/Agent Toxicity by Tissue/Organ
Radiation Toxicity

Interventions: Biological: filgrastim
Drug: amifostine trihydrate
Drug: cisplatin
Drug: etoposide
Drug: paclitaxel
Drug: topotecan hydrochloride
Radiation: radiation therapy

First Posted Date: 2003-10-08

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 73

Registration Number: NCT00006012

Locations: 🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸
Siouxland Regional Cancer Center, Sioux City, Iowa, United States
🇺🇸
St. Elizabeth Regional Medical Center, Lincoln, Nebraska, United States

and more 81 locations

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Phase 2

Completed

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Adult Acute Myeloid Leukemia in Remission

Interventions: Biological: filgrastim
Biological: Anti-Thymocyte Globulin
Drug: busulfan
Drug: fludarabine phosphate
Drug: methotrexate
Drug: tacrolimus
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

First Posted Date: 2003-10-07

Last Posted Date: 2018-06-12

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 121

Registration Number: NCT00070135

Locations: 🇺🇸
New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States
🇺🇸
Mount Sinai Medical Center, New York, New York, United States
🇺🇸
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

and more 18 locations

Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: carboplatin
Drug: celecoxib
Drug: gemcitabine hydrochloride
Drug: zileuton

First Posted Date: 2003-10-07

Last Posted Date: 2016-06-30

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 140

Registration Number: NCT00070486

Locations: 🇺🇸
Veterans Affairs Medical Center - Columbia (Truman Memorial), Columbia, Missouri, United States
🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
🇺🇸
CCOP - North Shore University Hospital, Manhasset, New York, United States

and more 72 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy